Skip to content

Efficacy and safety of a two-step method of skin preparation for peripheral intravenous catheter insertion - a prospective multicentre randomised trial

Efficacy and safety of a two-step method of skin preparation for peripheral intravenous catheter insertion - a prospective multicentre randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN01075518
Enrollment
248
Registered
2006-06-19
Start date
2004-05-01
Completion date
Unknown
Last updated
2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related septic thrombophlebitis Circulatory System Thrombophlebitis

Interventions

With the intention of encouraging compliance with the recommendations, we have developed a simplified, effective method for skin preparation for the insertion of PVCs, involving two successive swabbin

Sponsors

West Scientific Coordination Center for the Fight against Nosocomial Infections (CCLIN) (France)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Hospitalised, consenting adults aged over 18 years 2. Male or female 3. Requiring the insertion of a continuous PVC with a treatment duration of more than 48 hours 4. Those for whom either skin preparation procedure could be used

Exclusion criteria

Exclusion criteria: 1. The insertion of a catheter for emergency perfusion 2. Allergy to povidone 3. A planned intravenous treatment time of less than 48 hours 4. The presence of skin lesions at the chosen insertion site 5. Being in the last three months of pregnancy 6. Refusal to give consent 7. Patient unconscious or incapable of understanding the information given

Design outcomes

Secondary

MeasureTime frame
No secondary outcome measures

Primary

MeasureTime frame
The appearance of precursor signs of infection at the insertion site, as evaluated according to the Maddox scale. The nurses were trained in the use of this scale before the start of the study.

Countries

France

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026